【摘 要】
：
Background To evaluate the efficiency of thrombus aspiration during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).Methods Databases incl
【机 构】
：
The First Affiliated Hospital of Xinjiang Medical University,Xinjiang,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
论文部分内容阅读
Background To evaluate the efficiency of thrombus aspiration during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).Methods Databases including the Cochrane Library,PubMed,EMbase,CNKI,WanFang Data were searched from inception to June 2013 to identify the randomized controlled trials (RCTs) on thrombus aspiration during primary PCI for acute ST-segment elevation myocardial infarction.Two reviewers independently selected the literature according to the inclusion and exclusion criteria,extracted data,and assessed methodological quality of the included studies.Then the meta-analysis was conducted using RevMan5.0 software.
其他文献
Background Coronary artery calcium (CAC) score is associated with coronary atherosclerosis,but the relationship between CAC score and the procedure complexity,procedure-related complications and long-
Background Although percutaneous transluminal septal myocardial ablation (PTSMA) has been considered to be a new interventional technique to treat patients with hypertrophic obstructive cardiomyopathy
Background We investigated whether an additional intracoronary tirofiban bolus administration following upstream intravenous treatment could further improve myocardial reperfusion and clinical outcome
Background High on-treatment platelet reactivity (HPR) is deemed as an independent predictor for ischemic events in patients with acute coronary syndromes (ACS).However,the optimal treatment strategy
Background Recently,a chronic total occlusion (CTO) in the non-infarct-related artery (non-IRA) was reported as an independent predictor of clinical outcome in patients with acute ST-segment elevation
Background Previous studies demonstrated higher rates of adverse cardiac events and restenosis in patients with small vessel disease.No large-scale clinical study of everolimus-eluting stents (EES) wa
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diabetes patients.The intention of this subgroup analysis was to compare the safety and effe
Background Myocardial fractional flow reserve (FFR) is an indispensable tool to identify individual coronary stenoses causing ischemia.Calculation of FFR from X-ray angiographic data alone may increas
Background Bare metal (BMS) and drug-eluting stents (DES) have decreased the need of target vessel revascularization (TVR) in primary percutaneous coronary intervention (PPCI),at the expense of the ri
Background Biodegradable polymer drug-eluting stents (BPDES) have been developed to address the risk of stent thrombosis.The EXCEL stent (JW Medical Systems,Weihai,China) features an abluminal PLA dru